Inhibrx Biosciences Statistics Share Statistics Inhibrx Biosciences has 14.49M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 14.49M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) 69.99% Shares Floating 9.86M Failed to Deliver (FTD) Shares 192 FTD / Avg. Volume 0.16%
Short Selling Information The latest short interest is 748.15K, so 5.16% of the outstanding
shares have been sold short.
Short Interest 748.15K Short % of Shares Out 5.16% Short % of Float 7.12% Short Ratio (days to cover) 8.8
Valuation Ratios The PE ratio is 0.13 and the forward
PE ratio is -2.97.
Inhibrx Biosciences's PEG ratio is
0.
PE Ratio 0.13 Forward PE -2.97 PS Ratio 1114.64 Forward PS 94.5 PB Ratio 1.67 P/FCF Ratio -1.13 PEG Ratio 0
Financial Ratio History Enterprise Valuation Inhibrx Biosciences has an Enterprise Value (EV) of 78.38M.
EV / Sales 391.9 EV / EBITDA 0.05 EV / EBIT -0.4 EV / FCF -0.4
Financial Position The company has a current ratio of 3.94,
with a Debt / Equity ratio of 0.06.
Current Ratio 3.94 Quick Ratio 3.94 Debt / Equity 0.06 Debt / EBITDA n/a Debt / FCF -0.04 Interest Coverage -24.57
Financial Efficiency Return on Equity is 1263.3% and Return on Invested Capital is -234.02%.
Return on Equity 1263.3% Return on Assets 933.56% Return on Invested Capital -234.02% Revenue Per Employee $1.28K Profits Per Employee $10.82M Employee Count 156 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 2K Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 87.12% in the
last 52 weeks. The beta is 0.31, so Inhibrx Biosciences's
price volatility has been higher than the market average.
Beta 0.31 52-Week Price Change 87.12% 50-Day Moving Average 22.52 200-Day Moving Average 15.78 Relative Strength Index (RSI) 72.47 Average Volume (20 Days) 117,141
Income Statement In the last 12 months, Inhibrx Biosciences had revenue of 200K
and earned 1.69B
in profits. Earnings per share was 116.58.
Revenue 200K Gross Profit -2.08M Operating Income -331.45M Net Income 1.69B EBITDA 1.7B EBIT 1.7B Earnings Per Share (EPS) 116.58
Full Income Statement Balance Sheet The company has 152.6M in cash and 8.05M in
debt, giving a net cash position of 144.55M.
Cash & Cash Equivalents 152.6M Total Debt 8.05M Net Cash 144.55M Retained Earnings -106.13M Total Assets 212.12M Working Capital 155.03M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -194.41M
and capital expenditures -2.6M, giving a free cash flow of -197.01M.
Operating Cash Flow -194.41M Capital Expenditures -2.6M Free Cash Flow -197.01M FCF Per Share -13.61
Full Cash Flow Statement Margins Gross margin is -1042.5%, with operating and profit margins of -165724% and 843786%.
Gross Margin -1042.5% Operating Margin -165724% Pretax Margin 843787% Profit Margin 843786% EBITDA Margin 851675% EBIT Margin -165724% FCF Margin -98503%
